Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Hecht Beth (CIK 1652410) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-01). Recent activity: Sell XERS (16,666 shares), Sell XERS (16,666 shares), Sell XERS (16,666 shares), Sell XERS (16,667 shares), Sell XERS (16,667 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,666 | $141,434 |
| 2026-08-04 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,666 | $133,553 |
| 2026-07-02 | Xeris Biopharma Holdings, Inc. (XERS) | See Remarks | Sell | 16,666 | $133,860 |
| 2026-06-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,667 | $101,002 |
| 2026-05-01 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,667 | $103,835 |
| 2026-04-03 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,667 | $99,835 |
| 2026-03-04 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,567 | $103,378 |
| 2026-03-04 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 100 | $706 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Buy | 121,293 | $0 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 98,375 | $724,040 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 46,914 | $345,287 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 24,266 | $178,598 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,667 | $124,169 |
| 2026-01-05 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,667 | $123,836 |
| 2025-12-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,667 | $116,836 |
| 2025-11-13 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Legal Officer and Corporate Secretary | Sell | 16,667 | $123,336 |
Source: SEC Form 4 filings · as of 2026-09-01